Page 9 - 2019_01-Haematologica-web

haematologica Journal of the Ferrata Storti Foundation
e4 Effects of erythropoiesis-stimulating agents on overall survival of International Prognostic Scoring System Low/Intermediate-1 risk, transfusion-independent myelodysplastic syndrome patients: a cohort study
Emanuela Messa et al.
http://www.haematologica.org/content/104/1/e4
e9 Impact of FLT3-ITD length on prognosis of acute myeloid leukemia Song-Bai Liu et al.
http://www.haematologica.org/content/104/1/e9
e13 Long-term follow up of pediatric Philadelphia positive acute lymphoblastic leukemia treated with the EsPhALL2004 study: high white blood cell count at diagnosis is the strongest prognostic factor
Andrea Biondi et al.
http://www.haematologica.org/content/104/1/e13
e17 Pre-clinical evaluation of second generation PIM inhibitors for the treatment of T-cell acute lymphoblastic leukemia and lymphoma Renate De Smedt et al.
http://www.haematologica.org/content/104/1/e17
e21 Programmed cell death protein-1 (PD-1)-expression in the microenvironment of classical Hodgkin lymphoma at relapse during anti-PD- 1-treatment
Stephanie Sasse et al. http://www.haematologica.org/content/104/1/e21
e25 MYC protein expression scoring and its impact on the prognosis of aggressive B-cell lymphoma patients Maria R. Ambrosio et al.
http://www.haematologica.org/content/104/1/e25
e29 Incidence of upper-extremity deep vein thrombosis in western France: a community-based study Aurélien Delluc et al.
http://www.haematologica.org/content/104/1/e29
Case Reports
Case Reports are available online only at www.haematologica.org/content/104/1.toc
e32 Lymphoproliferation, immunodeficiency and early-onset inflammatory bowel disease associated with a novel mutation in Caspase 8 Veronika Kanderova et al.
http://www.haematologica.org/content/104/1/e32
e35 B-lymphoblastic lymphoma with TCF3-PBX1 fusion gene Mari Kubota-Tanaka et al.
http://www.haematologica.org/content/104/1/e35
e38 Spatial clonal evolution leading to ibrutinib resistance and disease progression in chronic lymphocytic leukemia Richárd Kiss et al.
http://www.haematologica.org/content/104/1/e38
Comments
Comments are available online only at www.haematologica.org/content/104/1.toc
e42 Programmed cell death protein-1 (PD1) expression in the microenvironment of classical Hodgkin lymphoma is similar between favorable and adverse outcome and does not enrich over serial relapses with conventional chemotherapy
Joseph G. Taylor et al.
http://www.haematologica.org/content/104/1/e42
e45 Programmed cell death protein1 (PD1)-expression in the microenvironment of classical Hodgkin lymphoma at relapse after conventional chemotherapy and at relapse on anti-PD1 treatment
Stephanie Sasse et al.
http://www.haematologica.org/content/104/1/e45
Haematologica 2019; vol. 104 no. 1 - January 2019 http://www.haematologica.org/